UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000035627
Receipt No. R000040586
Official scientific title of the study Efficacy of eye wash trial with Wellwasheye
Date of disclosure of the study information 2019/01/22
Last modified on 2019/01/22 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Efficacy of eye wash trial with Wellwasheye
Title of the study (Brief title) Eye wash efficacy by Wellwasheye
Region
Japan

Condition
Condition Allergic conjunctivitis disease
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the effectiveness and safety of allergic conjunctiva disease by Wellwosseye
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes 1.Change in subjective symptom score (JACQLQ)
2.Changes in objective symptom score (JACQLQ)
3.Changes in conjunctival injection score
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Double blind -all involved are blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Wellwasheye
Interventions/Control_2 saline solution
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
13 years-old <
Age-upper limit
70 years-old >=
Gender Male and Female
Key inclusion criteria Patients with allergic conjunctivitis disease
Key exclusion criteria 1 Patients with a past history of ocular surgery.
2. Patient who can not use eye drops.
Target sample size 30

Research contact person
Name of lead principal investigator Tatsuya Mimura
Organization Teikyo University
Division name School of Medicine, Department of Ophthalmology
Address 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605 Japan
TEL 03-3964-1211
Email mimurat@med.teikyo-u.ac.jp

Public contact
Name of contact person Tatsuya Mimura
Organization Teikyo University
Division name School of Medicine, Department of Ophthalmology
Address 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605 Japan
TEL 03-3964-1211
Homepage URL
Email mimurat@med.teikyo-u.ac.jp

Sponsor
Institute Teikyo University School of Medicine
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor Department of Ophthalmology Tsurumi University Dental Hospital, Ryogoku Eye Clinic, Fujishima Eye Clinic
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 01 Month 22 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2019 Year 01 Month 22 Day
Anticipated trial start date
2019 Year 01 Month 22 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2019 Year 01 Month 22 Day
Last modified on
2019 Year 01 Month 22 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040586